Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRx™ Expansion
20 Febbraio 2024 - 10:05PM
Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract
research organization (CRO), today announced the opening of its
expanded non-commercial specialty pharmacy, FortreaRx™, located in
Lake Mary, Florida, which offers advanced patient access solutions
across the United States, including ambient and cold-chain
distribution capabilities and expertise.
Licensed in all 50 states and U.S. territories, FortreaRx
delivers flexible, scalable solutions that meet the specific needs
of its customers while providing medications to patients who may
otherwise not have access to them. Non-commercial specialty
pharmacies, like FortreaRx, provide these solutions on behalf of
their pharmaceutical manufacturer customers and are uniquely
positioned to serve as a bridge between pharmaceutical
manufacturers and patients who meet the manufacturer requirements
for prescription assistance.
Since FortreaRx’s inception in late 2008, Fortrea has pioneered
non-commercial specialty pharmacy services, focusing exclusively on
the distribution of free-goods products as an integrated component
of pharmaceutical manufacturer-sponsored patient assistance
programs (PAP) designed to expand access to therapy for qualified
patients with no health insurance or those who are underinsured.
The FortreaRx 40,000-square-foot facility doubles its operational
space and bolsters its capabilities, delivering:
- 1,800 square feet of ambient storage
- 6,000+ square feet of cold chain storage with more than 85
percent of prescriptions filled by FortreaRx requiring this unique
handling
- Greater processing and fulfillment space for up to 18,000
prescriptions daily
- Enhanced shipping solutions with options for overnight,
expedited and 2-day deliveries
"Fortrea’s well-established patient services offerings, combined
with the expanded capabilities of FortreaRx, deliver an end-to-end
approach, from early clinical stages to post-market delivery,
ensuring a comprehensive and personalized experience for patients,"
said Bill Nolan, vice president and global head of Patient Access
at Fortrea. "From our expertise in broad-range disease states to
our unwavering commitment to patient assistance, Fortrea excels at
delivering timely and impactful solutions to our pharmaceutical
sponsors that strive to reduce patient and provider challenges by
streamlining enrollment processes and by offering full integration
with broader patient support initiatives."
FortreaRx’s call center hub of case managers seamlessly manages
patient inquiries, counseling and data verification of
prescriptions. Fortrea’s patient access team helps patients and
providers understand and navigate the complexities of coverage
while removing obstacles to get medication to patients.
FortreaRx delivers efficient, consultative and cost-effective
solutions for manufacturer prescription programs typically
resulting in significant yearly savings for patients.
For more information about FortreaRx and its services, please
visit Fortrea.com.
About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical
development and patient access solutions to the life sciences
industry. We partner with emerging and large biopharmaceutical,
medical device and diagnostic companies to drive healthcare
innovation that accelerates life changing therapies to patients in
need. Fortrea provides phase I-IV clinical trial management,
clinical pharmacology, differentiated technology-enabled trial
solutions and post-approval services. Fortrea’s solutions leverage
three decades of experience spanning more than 20 therapeutic
areas, a passion for scientific rigor, exceptional insights and a
strong investigator site network. Our talented and diverse team of
about 19,000 people working in more than 90 countries is scaled to
deliver focused and agile solutions to customers globally. Learn
more about how Fortrea is becoming a transformative force from
pipeline to patient at Fortrea.com and follow us on LinkedIn and X
(formerly Twitter) @Fortrea.
Fortrea Contacts:Fortrea Media: Galen Wilson –
703-298-0802, media@fortrea.com Fortrea Media: Kate Dillon –
646-818-9115, kdillon@prosek.com
Grafico Azioni Fortrea (NASDAQ:FTRE)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Fortrea (NASDAQ:FTRE)
Storico
Da Dic 2023 a Dic 2024